# Nuclide record f-radioembolisation (section). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/fronts/f-radioembolisation/>
  a schema:DefinedTerm ;
  nuclide:kind "section" ;
  schema:identifier "f-radioembolisation" ;
  schema:name "Radioembolisation"@en ;
  schema:description "Radioembolisation delivers tiny radioactive beads directly into the blood vessels feeding a liver tumour through a catheter, so the radiation stays concentrated in the liver instead of spreading through the whole body."@en ;
  schema:url <https://nuclide.cc/fronts/f-radioembolisation/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.onclive.com/view/personalized-radioembolization-improves-os-vs-standard-dosing-in-advanced-hcc>, <https://www.bostonscientific.com/content/dam/bostonscientific/pi/portfolio-group/cancer-therapies/therasphere/resource-center/clinical-data/DOSISPHERE-01_Data_Sheet.pdf>, <https://www.mdpi.com/2072-6694/17/9/1494> ;
  nuclide:related <https://nuclide.cc/fronts/f-dosimetry/>, <https://nuclide.cc/fronts/f-bone-targeted/>, <https://nuclide.cc/isotopes/y-90/> ;
  nuclide:indications <https://nuclide.cc/indications/hcc/>, <https://nuclide.cc/indications/hcc-intermediate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioembolisation-tare/> ;
  nuclide:companies <https://nuclide.cc/companies/sirtex/>, <https://nuclide.cc/companies/boston-scientific/> ;
  nuclide:terms <https://nuclide.cc/terms/tare/> ;
  nuclide:trials <https://nuclide.cc/trials/sarah-sirvenib/>, <https://nuclide.cc/trials/nct06040099/> .